Oxazepam Léčiva

Oxazepam, the active ingredient in Oxazepam Léčiva, is a benzodiazepine presented as a tablet for oral use. It is primarily prescribed for the short‑term management of anxiety disorders and the relief of alcohol‑withdrawal symptoms in adult patients. GNH USA supplies Oxazepam Léčiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxazepam Léčiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxazepam is a benzodiazepine that acts on the central nervous system to alleviate anxiety‑related conditions and related withdrawal states.

- Anxiety disorder: reduces excessive worry and tension in adult patients. - Alcohol withdrawal: eases tremor, agitation and risk of seizures during detoxification. - Pre‑operative sedation: provides short‑acting calming effect before surgical procedures.

Adverse reactions to oxazepam may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate cranial pain. - Impaired coordination: reduced motor control or clumsiness. - Gastrointestinal discomfort: nausea, upset stomach or constipation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, particularly at high doses or with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts or aggressive behaviour. - Paradoxical reactions: increased anxiety, agitation or hostility. - Dependence and withdrawal: physical or psychological reliance after prolonged use.

Before prescribing oxazepam, clinicians should evaluate patient history and monitor for potential risks.

- Assess liver function: adjust use in patients with hepatic impairment. - Review concomitant CNS depressants: avoid additive sedation. - Monitor elderly patients: increased sensitivity to sedative effects. - Caution in pregnancy: weigh benefits against potential fetal risks. - Advise against abrupt discontinuation: taper dose to minimise withdrawal. - Store at ambient temperature: keep in original container, protect from moisture and light.

Oxazepam can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression. - Barbiturates: additive CNS depression increases risk of overdose. - Alcohol: synergistic sedative effect heightens impairment.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase serotonergic activity. - Antihistamines: can enhance drowsiness. - Anticonvulsants (phenytoin, carbamazepine): may reduce oxazepam plasma levels.